Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00211250 · ClinicalTrials.gov registry record · Phase 4
Comparing Compliance, Tolerability, Efficacy and Adverse Events in Bipolar Tients From Valproic Acid to Depakote ER
A Phase 4 study of Mood Disorder, sponsored by Joliet Center for Clinical Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT00211250: Completed Phase 4 study of Mood Disorder, sponsored by Joliet Center for Clinical Research.
NCT00211250 is a Phase 4 study of Mood Disorder that has completed, run by Joliet Center for Clinical Research. The registered enrollment target is 20 participants, below the 1,305-participant average among 7 other Mood Disorder trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00211250, a Phase 4 study of Mood Disorder, has completed, sponsored by Joliet Center for Clinical Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare compliance, tolerability, effectiveness, and side-effects in Bipolar I and II patients switching from Valproic Acid to Depakote ER.
Conditions Studied
Interventions
- DRUG Valproic Acid and Depakote ER
Study Locations (1)
Illinois
- Cosme Lozano M.D. - Joliet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2005-07 |
| Est. Completion | 2006-09 |
| Phase | Phase 4 |
What the finished NCT00211250 record still lists
NCT00211250 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,305-participant average among 7 other Mood Disorder trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Mood Disorder appearing as the primary indexed condition, and to 1 intervention - of which Valproic Acid and Depakote ER is the first listed.
NCT00211250 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT00211250 about?
NCT00211250 is a clinical study titled "Comparing Compliance, Tolerability, Efficacy and Adverse Events in Bipolar Tients From Valproic Acid to Depakote ER". The purpose of this study is to compare compliance, tolerability, effectiveness, and side-effects in Bipolar I and II patients switching from Valproic Acid to Depakote ER.
What is the current status of trial NCT00211250?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2005-07. Estimated completion is 2006-09.
What conditions does trial NCT00211250 study?
This clinical trial studies the following conditions: Mood Disorder.
What interventions are being tested in trial NCT00211250?
The interventions under investigation include: Valproic Acid and Depakote ER (DRUG).
Who is sponsoring clinical trial NCT00211250?
This trial is sponsored by Joliet Center for Clinical Research, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00211250 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mood Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Studies of Brain Function and Course of Illness in Pediatric Bipolar Disorder
RECRUITING
-
Study of Premenstrual Syndrome and Premenstrual Dysphoria
RECRUITING
-
Adolescence, Puberty, and Emotion Regulation
COMPLETED
-
Perimenopause-Related Mood and Behavioral Disorders
COMPLETED
-
Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and Volunteers
COMPLETED
-
Oxytocin on Irritability/Emotional Dysregulation of Disruptive Behavior and Mood Disorders
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia